Xuemin Gu
About Xuemin Gu
Xuemin Gu is a Principal Biostatistician at Bristol-Myers Squibb in New York, with a diverse background in both the pharmaceutical industry and cancer research.
Title and Current Role
Xuemin Gu currently holds the position of Principal Biostatistician at Bristol-Myers Squibb. He operates out of New York, New York, United States. In this role, he applies his extensive expertise in biostatistics to advance the company's pharmaceutical research and development efforts.
Professional Experience
Xuemin Gu has garnered extensive experience across various pharmaceutical companies and research institutions. Prior to his current role, he served as a Principal Biostatistician and Senior Biostatistician at Regeneron Pharmaceuticals, Inc. from 2013 to 2014. He also held the position of Research Scientist at Eli Lilly and Company from 2011 to 2013. From 2008 to 2011, Gu contributed significantly to cancer research as a Statistical Analyst at MD Anderson Cancer Center in Houston, Texas, United States. His professional journey began as a Product Engineer at Musashi North America from 2005 to 2006.
Education and Expertise
Xuemin Gu's academic background includes a Doctor of Philosophy from the University of Texas - Houston and another Doctor of Philosophy from the University of Illinois at Urbana - Champaign. He also holds a Bachelor’s degree from Tsinghua University. These educational achievements have equipped him with a robust foundation in biostatistics and research methodologies, underpinned by a comprehensive understanding of both theoretical and applied statistics.
Industry and Research Contributions
Throughout his career, Xuemin Gu has bridged the gap between academia and industry. His tenure at MD Anderson Cancer Center involved substantial contributions to cancer research, applying statistical methods to oncological studies. In the pharmaceutical industry, he leveraged his statistical expertise at companies like Regeneron Pharmaceuticals and Eli Lilly to enhance their drug development processes. His multidisciplinary experience reflects a versatile approach, encompassing both the pharmaceutical and research sectors.
Transition from Engineering to Biostatistics
Xuemin Gu's transition from a Product Engineer role at Musashi North America to careers in biostatistics and research underscores his adaptability and diverse skill set. This career shift highlights his ability to apply quantitative and analytical skills across different domains, from engineering to biostatistics, fostering a unique blend of technical expertise and practical experience.